Greater incidence of depression with hypnotic use than with placebo

BMC Psychiatry

Volumn 7, Issue , 2007, Pages

  Kripke, Daniel F ^a,b  

^a SCRIPPS CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; ESZOPICLONE; FLUOXETINE; FLURAZEPAM; HYPNOTIC AGENT; PLACEBO; RAMELTEON; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRAZODONE; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ACETAMIDE DERIVATIVE; AZABICYCLO DERIVATIVE; HYPNOTIC SEDATIVE AGENT; INDENE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DRUG CONTRAINDICATION; DRUG USE; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HUMAN; INCIDENCE; INSOMNIA; MONOTHERAPY; PRESCRIPTION; RISK ASSESSMENT; UNITED STATES; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; FOLLOW UP; LONG TERM CARE; MAJOR DEPRESSION; RANDOMIZED CONTROLLED TRIAL; RISK;

ACETAMIDES; AZABICYCLO COMPOUNDS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FOLLOW-UP STUDIES; HUMANS; HYPNOTICS AND SEDATIVES; INCIDENCE; INDENES; LONG-TERM CARE; ODDS RATIO; PIPERAZINES; PRESCRIPTIONS, DRUG; PYRIDINES; PYRIMIDINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP INITIATION AND MAINTENANCE DISORDERS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34848863972     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-7-42     Document Type: Article

References (26)

1. Ford DE Kamerow DB Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA 1989, 262:1479-1484. 10.1001/jama.262.11.1479 2769898
2. Chang PP Ford DE Mead LA Cooper-Patrick L Klag MJ Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study Am J Epidemiol 1997, 146:105-114. 9230772
3. Association AP Diagnostic and Statistical Manual of Mental Disorders: DSM-IV Washington, D.C., American Psychiatric Association Fourth Edition, Text Revision 2000.
4. Breslau N Roth T Rosenthal L Andreski P Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults Biol Psychiat 1996, 39:411-418. 10.1016/0006-3223(95)00188-3 8679786
5. Roberts RE Shema SJ Kaplan GA Strawbridge WJ Sleep complaints and depression in an aging cohort: A prospective perspective Am J Psychiatry 2000, 157:81-88. 10618017
6. Fogel J Eaton WW Ford DE Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up Acta Psychiatr Scand 2006, 113:36-43. 10.1111/j.1600-0447.2005.00654.x 16390367
7. Neckelmann D Mykletun A Dahl AA Chronic insomnia as a risk factor for developing anxiety and depression Sleep 2007, 30:873-880. 17682658
8. Drugs@FDA 2006 http://www.accessdata.fda.gov/scripts/cder/drugsatfda/
9. Krystal AD Walsh JK Laska E Caron J Amato DA Wessel TC Roth T Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia Sleep 2003, 26:793-799. 14655910
10. Allgulander C Nasman B Regular hypnotic drug treatment in a sample of 32,679 Swedes: Associations with somatic and mental health, inpatient psychiatric diagnoses and suicide, derived with automated record-linkage Psychosom Med 53(1):101-108.
11. Kripke DF Klauber MR Wingard DL Fell RL Assmus JD Garfinkel L Mortality hazard associated with prescription hypnotics Biol Psychiatry 1998, 43:687-693. 10.1016/S0006-3223(97)00292-8 9583003
12. Kripke DF Evidence That New Hypnotics Cause Cancer eScholarship Repository, University of California 2006 http://repositories.cdlib.org/ ucsdpsych/3
13. Wirz-Justice A van den Hoofdakker RH Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 1999, 46:445-453. 10.1016/S0006-3223(99)00125-0 10459393
14. Buscemi N Vandermeer B Friesen C Bialy L Tubman M Ospina M Klassen TP Witmans M The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTs J Gen Intern Med 2007. 17619935
15. Morin CM Colecchi C Stone J Sood R Brink D Behavioral and pharmacological therapies for late-life insomnia. A randomized controlled trial JAMA 1999, 281:991-999. 10.1001/jama.281.11.991 10086433
16. Jacobs GD Pace-Schott EF Stickgold R Otto MW Cognitive behavior therapy and pharmacotherapy for insomnia Arch Intern Med 2004, 164:1888-1896. 10.1001/archinte.164.17.1888 15451764
17. Sivertsen B Omvik S Pallesen S Bjorvatn B Havik OE Kvale G Nielsen GH Nordhus IH Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: A randomized controlled trial JAMA 2006, 295:2851-2858. 10.1001/jama.295.24.2851 16804151
18. Morin CM Bootzin RR Buysse DJ Edinger JD Espie CA Lichstein KL Psychological and behavioral treatment of insomnia:uPdate of the recent evidence (1998-2004) Sleep 2006, 29:1398-1414. 17162986
19. Morgan K Dixon S Mathers N Thompson J Tomeny M Psychological treatment for insomnia in the regulation of long-term hypnotic drug use Health Technol Assess 2004, 8:iIi-68. 14960254
20. Dixon S Morgan K Mathers N Thompson J Tomeny M Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia Behav Sleep Med 2006, 4:71-84. 10.1207/ s15402010bsm0402_1 16579717
21. Fava M McCall WV Krystal A Wessel T Rubens R Caron J Amato D Roth T Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder Biol Psychiatry 2006, 59:1052-1060. 10.1016/j.biopsych.2006.01.016 16581036
22. Rush AJ Armitage R Gillin JC Yonkers KA Winokur A Moldofsky H Vogel GW Kaplita SB Fleming JB Montplaisir J Erman MK Albala BJ McQuade RD Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder Biol Psychiatry 1998, 44:3-14. 10.1016/ S0006-3223(98)00092-4 9646878
23. Giles J Drug trials: Stacking the deck Nature 2006, 440:270-272. 10.1038/ 440270a 16541043
24. Asnis GM Chakraburtty A Duboff EA Krystal A Londborg PD Rosenberg R Roth-Schechter B Scharf MB Walsh JK Zolpidem for persistent insomnia in SSRI-treated depressed patients J Clin Psychiatry 1999, 60(10):1453-1461.
25. Soares CN Joffe H Rubens R Caron J Roth T Cohen L Eszopiclone in patients with insomnia during perimenopause and early postmenopause: A randomized controlled trial Obstet Gynecol 2006, 108:1402-1410. 17138773
26. Kripke DF The Dark Side of Sleeping Pills 2006. http://www.DarkSideOfSleepingPills.com